title: Fecal microbiota transplant protocol for clostridium difficile infection.
abstract: Fecal microbiota transplant has become more acceptable as a therapeutic for recurrent Clostridium difficile infection. The FDA has an enforcement discretion policy for practitioner's performing this therapy, which includes informed consent for this experimental treatment. This manuscript describes a typical procedure that can be followed that includes the important aspects of this preparation and treatment.
authors: Emory University School of Medicine, Atlanta, Georgia.
authors: William M
authors: WM
authors: Tauxe
authors: Division of Digestive Diseases, Emory University School of Medicine, Atlanta, Georgia.
authors: Tanvi
authors: T
authors: Dhere
authors: Division of Digestive Diseases, Emory University School of Medicine, Atlanta, Georgia.
authors: Angela
authors: A
authors: Ward
authors: Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
authors: Lori D
authors: LD
authors: Racsa
authors: Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia.
authors: Jay B
authors: JB
authors: Varkey
authors: Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia colleen.kraft@emory.edu.
authors: Colleen S
authors: CS
authors: Kraft
mesh_terms: D002985:Clinical Protocols / Q000592:standards*; D016360:Clostridioides difficile / Q000472:pathogenicity*; D003015:Clostridium Infections / Q000601:surgery*; D000069467:Fecal Microbiota Transplantation / Q000379:methods* / Q000592:standards*; D006801:Humans
keywords: CDI; Clostridium difficile; FMT; fecal microbiota transplant; stool